Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America Health Times.
Press releases published on April 9, 2025
Sarcomatrix Renews United States Orphan Drug Designation for LAMA2-Related Muscular Dystrophy Program
EIN Presswire
·
April 9, 2025
RENO, NV, UNITED STATES, April 9, 2025 /EINPresswire.com/ -- Sarcomatrix Therapeutics, a privately held biopharmaceutical company advancing transformative therapies for severe muscle diseases, today announced the renewal of its Orphan Drug Designation ( …
SABER College’s PTA Program Offers a Path to a Purpose-Driven Career in Healthcare
EIN Presswire
·
April 9, 2025
Now enrolling for April 28: Get hands-on training and ESOL support to build a future in physical therapy. Financial aid available for those who qualify. MIAMI, FL, UNITED STATES, April 9, 2025 /EINPresswire.com/ -- In a time when the healthcare industry …
NurExone Biologic Inc. Announces Fourth Quarter and Full-Year 2024 Financial Results and Provides Corporate Update
GlobeNewswire
·
April 9, 2025
TORONTO and HAIFA, Israel, April 10, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) is pleased to provide a business update and reported financial results for the fourth quarter and …
Codexis Announces Byron Dorgan to Retire from Board of Directors
GlobeNewswire
·
April 9, 2025
REDWOOD CITY, Calif., April 09, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced that Byron Dorgan will retire from the Company’s Board …
COSCIENS Biopharma Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Corporate Update
GlobeNewswire
·
April 9, 2025
Fully repositioned as a pure-play natural-based product company following strategic review and pipeline prioritization Ongoing streamlined efficiencies and cost cutting measures taken to refine operations and development pathway forward; Company ended the …
Procaps Group assegura um investimento de capital de 130 milhões de dólares e conclui uma reestruturação abrangente de dívidas, enquanto novos investidores assumem a liderança estratégica
GlobeNewswire
·
April 9, 2025
Novos investidores assumem a liderança estratégica enquanto a sede é transferida para Bogotá, marcando o início de um novo capítulo de crescimento, execução e transformação sob uma governança aprimorada A empresa acelera sua reviravolta com mudanças na …
Procaps Group asegura una inversión de capital de 130 millones de dólares y completa una reestructuración integral de deuda, mientras nuevos inversores asumen el liderazgo estratégico
GlobeNewswire
·
April 9, 2025
Nuevos inversores asumen el liderazgo estratégico mientras la sede se traslada a Bogotá, marcando el comienzo de un nuevo capítulo de crecimiento, ejecución y transformación bajo una gobernanza mejorada La empresa acelera su recuperación con cambios en el …
Procaps Group Secures $130 Million in Equity Investment and Completes Comprehensive Debt Restructuring, as New Investors Take Over Strategic Leadership
GlobeNewswire
·
April 9, 2025
New Investors Take Over the Strategic Leadership as Headquarters Move to Bogotá, Marking the Start of a New Chapter of Growth, Execution, and Transformation under Enhanced Governance Company Accelerates Turnaround with Leadership Changes, Regional …
Venus Concept Announces $1.1 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
GlobeNewswire
·
April 9, 2025
TORONTO, April 09, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has entered into definitive agreements for the purchase and sale of 328, …
Tempest Announces Plan to Explore Strategic Alternatives to Advance Promising Pipeline of Clinical Oncology Assets and Maximize Stockholder Value
GlobeNewswire
·
April 9, 2025
Amezalpat (TPST-1120) is Phase 3-ready: completed FDA and EMA interactions for first-line pivotal study in hepatocellular carcinoma (HCC); global investigator support in place Awarded both Orphan Drug …
Beyond Air Publishes Article in Annals of the American Thoracic Society Journal Highlighting NTM-PD Patients’ Ability to Safely Self-Administer High-Dose Intermittent iNO Treatments Using the LungFit™ GO at Home
GlobeNewswire
·
April 9, 2025
GARDEN CITY, N.Y., April 09, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve the lives …
Iridex to Host Strategic Vision Call on April 16, 2025
GlobeNewswire
·
April 9, 2025
MOUNTAIN VIEW, Calif., April 09, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal …
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 9, 2025
BRISBANE, Calif., April 09, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on April 3, 2025, the Compensation Committee granted inducement awards consisting of non-qualified stock options to purchase 211,250 shares of …
AVITA Medical to Present Breakthrough Clinical Data in Burn and Wound Care at ABA 2025
GlobeNewswire
·
April 9, 2025
VALENCIA, Calif., April 09, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering a portfolio of transformative solutions, today announced 16 abstracts to be presented at the …
Corvus Pharmaceuticals Appoints Richard A. van den Broek to Board of Directors
GlobeNewswire
·
April 9, 2025
SOUTH SAN FRANCISCO, Calif., April 09, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, announced today that Richard van den Broek, managing partner at HSMR Advisors, has been appointed to …
Tevogen Announces Tevogen Generics, a New Effort in Support of President Trump’s Initiative to Encourage Pharmaceutical Manufacturing in United States
GlobeNewswire
·
April 9, 2025
WARREN, N.J., April 09, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announces its newest effort: Tevogen Generics. This effort is in response to the growing national focus on pharmaceutical …
Cosmos Health Further Expands Facility Upgrades Program at Cana Laboratories and Signs 5-Year Contract Manufacturing Agreement with Pharmex for 1.5 Million Bottles of the Antiseptic Drug AMBITASOL 1L
GlobeNewswire
·
April 9, 2025
CHICAGO, April 09, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R…
Sodium Channel Blockers Clinical Trial Pipeline Accelerates as 20+ Pharma Companies Rigorously Developing Drugs for Market Entry | DelveInsight
GlobeNewswire
·
April 9, 2025
New York, USA, April 09, 2025 (GLOBE NEWSWIRE) -- Sodium Channel Blockers Clinical Trial Pipeline Accelerates as 20+ Pharma Companies Rigorously Developing Drugs for Market Entry | DelveInsight The sodium channel blocker market is expanding due to the …
SimiTree Talent Solutions Celebrates 20 Years of Excellence in Home Health, Hospice, and Behavioral Health Recruiting
GlobeNewswire
·
April 9, 2025
Hamden, CT, April 09, 2025 (GLOBE NEWSWIRE) -- SimiTree Talent Solutions, the specialized Recruiting, Executive Search, and Interim Leadership arm of SimiTree, proudly marks 20 years of success in recruiting, interim leadership, and executive placement for …
JAAD Publishes Study on AVAVA’s Focal Point Technology™, A Breakthrough in Laser Treatments for All Skin Tones
GlobeNewswire
·
April 9, 2025
BOSTON and NEW YORK, April 09, 2025 (GLOBE NEWSWIRE) -- AVAVA, a leader in medical aesthetics innovation, recently published a groundbreaking peer-reviewed study in the Journal of the American Academy of Dermatology (JAAD). This study highlights the power …